184 related articles for article (PubMed ID: 27604142)
1. Concurrent gastrointestinal perforation and pulmonary embolism due to bevacizumab in an adult undergoing treatment for stage IV colon cancer.
Qureshi S; Elliott RB; Herrington JD
J Oncol Pharm Pract; 2017 Dec; 23(8):625-628. PubMed ID: 27604142
[TBL] [Abstract][Full Text] [Related]
2. Bevacizumab-induced intestinal perforation in a patient with inoperable breast cancer: a case report and review of the literature.
Fujii Y; Hirahara N; Kaji S; Taniura T; Hyakudomi R; Yamamoto T; Tajima Y
J Med Case Rep; 2018 Mar; 12(1):84. PubMed ID: 29580267
[TBL] [Abstract][Full Text] [Related]
3. [Ischemic anastomotic bowel perforation during treatment with bevacizumab 10 months after surgery].
Abbrederis K; Kremer M; Schuhmacher C
Chirurg; 2008 Apr; 79(4):351-5. PubMed ID: 17453167
[TBL] [Abstract][Full Text] [Related]
4. Ileal perforation following cetuximab and FOLFIRI chemotherapy in a patient with ascending colon cancer with peritoneal carcinomatosis.
Kim YW
J BUON; 2017; 22(3):804-805. PubMed ID: 28730797
[No Abstract] [Full Text] [Related]
5. Gastrointestinal perforation in metastatic colorectal cancer patients with peritoneal metastases receiving bevacizumab.
Roohullah A; Wong HL; Sjoquist KM; Gibbs P; Field K; Tran B; Shapiro J; Mckendrick J; Yip D; Nott L; Gebski V; Ng W; Chua W; Price T; Tebbutt N; Chantrill L
World J Gastroenterol; 2015 May; 21(17):5352-8. PubMed ID: 25954110
[TBL] [Abstract][Full Text] [Related]
6. Posterior Reversible Encephalopathy Syndrome (PRES) Presenting as Status Epilepticus: A Case Report and Literature Review.
Sharma P; Abbas MK; Huynh M
Conn Med; 2016 Sep; 80(8):475-478. PubMed ID: 29782783
[TBL] [Abstract][Full Text] [Related]
7. [Two Cases of Bowel Perforation during Chemotherapy with Bevacizumab to Metastatic Rectal Cancer].
Miyake Y; Ikeda K; Murakami M; Oka Y; Nezu R; Kurokawa E; Kikkawa N
Gan To Kagaku Ryoho; 2015 Dec; 42 Suppl 1():75-8. PubMed ID: 26809419
[TBL] [Abstract][Full Text] [Related]
8. Clinical predictors of bevacizumab-associated intestinal perforation in non-small cell lung cancer.
Tamiya M; Suzuki H; Shiroyama T; Tanaka A; Morishita N; Okamoto N; Sakai K; Shigeoka H; Kawahara K; Hirashima T
Invest New Drugs; 2018 Aug; 36(4):696-701. PubMed ID: 29536229
[TBL] [Abstract][Full Text] [Related]
9. [A Case of Gastrointestinal Perforation in a Patient with Colon Cancer and Stent Placement during Bevacizumab Treatment, Alleviated with Conservative Therapy].
Chida S; Matsumoto S; Inoue N; Takenoshita S
Gan To Kagaku Ryoho; 2015 Nov; 42(12):2148-50. PubMed ID: 26805293
[TBL] [Abstract][Full Text] [Related]
10. [A Case That Was Complicated with Pulmonary Artery Thrombosis during Chemotherapy of the Regimen of CapeOX plus Bevacizumab against Recurrence of Colon Cancer].
Hariu T; Nako Y; Furutani A; Yamasaki S; Kitade T; Wakasa M; Sonoyama T
Gan To Kagaku Ryoho; 2018 Dec; 45(13):2330-2332. PubMed ID: 30692454
[TBL] [Abstract][Full Text] [Related]
11. Rare Case of Endoscopic Treatment for Bevacizumab-Related Gastric Perforation in a Patient with Ovarian Cancer.
Cappuccio S; Marinucci B; Bove V; Turco LC; Cosentino F; Scambia G; Costamagna G; Boškoski I
Chemotherapy; 2020; 65(1-2):54-57. PubMed ID: 32615577
[TBL] [Abstract][Full Text] [Related]
12. Gastrointestinal perforation due to bevacizumab in colorectal cancer.
Saif MW; Elfiky A; Salem RR
Ann Surg Oncol; 2007 Jun; 14(6):1860-9. PubMed ID: 17356952
[TBL] [Abstract][Full Text] [Related]
13. Randomized controlled trial of irinotecan drug-eluting beads with simultaneous FOLFOX and bevacizumab for patients with unresectable colorectal liver-limited metastasis.
Martin RC; Scoggins CR; Schreeder M; Rilling WS; Laing CJ; Tatum CM; Kelly LR; Garcia-Monaco RD; Sharma VR; Crocenzi TS; Strasberg SM
Cancer; 2015 Oct; 121(20):3649-58. PubMed ID: 26149602
[TBL] [Abstract][Full Text] [Related]
14. When a good call leads to a bad connection: colovesical fistula in colorectal cancer treated with bevacizumab.
Chen J; Smalligan RD; Nadesan S
Hosp Pract (1995); 2016 Aug; 44(3):120-2. PubMed ID: 27309405
[TBL] [Abstract][Full Text] [Related]
15. Bevacizumab safety in Japanese patients with colorectal cancer.
Hatake K; Doi T; Uetake H; Takahashi Y; Ishihara Y; Shirao K
Jpn J Clin Oncol; 2016 Mar; 46(3):234-40. PubMed ID: 26774113
[TBL] [Abstract][Full Text] [Related]
16. Pazopanib- and bevacizumab-induced reversible heart failure in a patient with metastatic renal cell carcinoma: A case report.
Abdallah AO; Vallurupalli S; Kunthur A
J Oncol Pharm Pract; 2016 Jun; 22(3):561-5. PubMed ID: 25956420
[No Abstract] [Full Text] [Related]
17. Colonic perforation following endoscopic mucosal resection in a patient on bevacizumab treatment.
Kalaitzakis E; Havre RF; Willemoe GL; Meisner S
Endoscopy; 2016; 48 Suppl 1():E224-5. PubMed ID: 27341201
[No Abstract] [Full Text] [Related]
18. [Posterior Reversible Encephalopathy Syndrome (PRES): About 4 cases].
Chanal E; Bouleftour W; Rivoirard R; Bosaki C; Forges F; Jacquin JP; Fournel P; Mery B; Saban-Roche L
Presse Med; 2019 Oct; 48(10):1026-1031. PubMed ID: 31653541
[No Abstract] [Full Text] [Related]
19. Leucovorin, fluorouracil, and oxaliplatin plus bevacizumab versus S-1 and oxaliplatin plus bevacizumab in patients with metastatic colorectal cancer (SOFT): an open-label, non-inferiority, randomised phase 3 trial.
Yamada Y; Takahari D; Matsumoto H; Baba H; Nakamura M; Yoshida K; Yoshida M; Iwamoto S; Shimada K; Komatsu Y; Sasaki Y; Satoh T; Takahashi K; Mishima H; Muro K; Watanabe M; Sakata Y; Morita S; Shimada Y; Sugihara K
Lancet Oncol; 2013 Dec; 14(13):1278-86. PubMed ID: 24225157
[TBL] [Abstract][Full Text] [Related]
20. Association of hypertension and treatment outcomes in advanced stage non-small cell lung cancer patients treated with bevacizumab or non-bevacizumab containing regimens.
Yan LZ; Dressler EV; Adams VR
J Oncol Pharm Pract; 2018 Apr; 24(3):209-217. PubMed ID: 29284349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
